Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 3 | 2021 | 37 | 1.640 |
Why?
|
| Sinusitis | 3 | 2021 | 131 | 1.540 |
Why?
|
| Nasal Polyps | 2 | 2021 | 27 | 1.010 |
Why?
|
| Biological Therapy | 1 | 2021 | 58 | 0.780 |
Why?
|
| Asthma | 1 | 2021 | 871 | 0.440 |
Why?
|
| Chronic Disease | 2 | 2021 | 1819 | 0.270 |
Why?
|
| Craniopharyngioma | 1 | 2023 | 52 | 0.220 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 273 | 0.200 |
Why?
|
| Pituitary Neoplasms | 1 | 2023 | 203 | 0.190 |
Why?
|
| Heart Arrest | 1 | 2023 | 358 | 0.170 |
Why?
|
| Thyroglobulin | 1 | 2014 | 62 | 0.120 |
Why?
|
| Comorbidity | 1 | 2021 | 2352 | 0.120 |
Why?
|
| Anesthesia, Inhalation | 1 | 2012 | 25 | 0.110 |
Why?
|
| Anesthesia, Intravenous | 1 | 2012 | 42 | 0.110 |
Why?
|
| Proton Therapy | 1 | 2023 | 1577 | 0.110 |
Why?
|
| Iodine Radioisotopes | 1 | 2014 | 371 | 0.110 |
Why?
|
| Paranasal Sinuses | 1 | 2012 | 61 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2014 | 486 | 0.100 |
Why?
|
| Quality of Life | 2 | 2023 | 4532 | 0.090 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 15 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2009 | 26 | 0.090 |
Why?
|
| Endoscopy | 1 | 2012 | 479 | 0.090 |
Why?
|
| Intestinal Diseases | 1 | 2009 | 121 | 0.080 |
Why?
|
| Edema | 1 | 2009 | 267 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 1081 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 1866 | 0.060 |
Why?
|
| Tracheostomy | 1 | 2023 | 243 | 0.050 |
Why?
|
| Humans | 6 | 2023 | 261506 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 13658 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2023 | 2231 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 2083 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 344 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 2012 | 28 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 660 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 73 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 2012 | 62 | 0.030 |
Why?
|
| Propofol | 1 | 2012 | 80 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 665 | 0.030 |
Why?
|
| Child | 2 | 2023 | 29154 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 309 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 37905 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8223 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 2009 | 76 | 0.020 |
Why?
|
| Urine | 1 | 2009 | 143 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 597 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 703 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13310 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 32848 | 0.020 |
Why?
|
| Resuscitation | 1 | 2009 | 223 | 0.020 |
Why?
|
| Piperidines | 1 | 2012 | 1035 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 2588 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 2803 | 0.020 |
Why?
|
| Male | 4 | 2023 | 123000 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2063 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6009 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 2450 | 0.010 |
Why?
|
| Female | 3 | 2023 | 141928 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6086 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 3254 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 14889 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 7548 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 70117 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 12873 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 77950 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 86204 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 10331 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 29902 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 31252 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 59536 | 0.000 |
Why?
|